Boc-3-Chloro-L-Phenylalanine

Online Inquiry

CAT#CP11504
CAS114873-03-9
Synonyms/Alias114873-03-9;Boc-3-chloro-L-phenylalanine;Boc-L-3-Chlorophenylalanine;BOC-PHE(3-CL)-OH;(S)-2-((tert-Butoxycarbonyl)amino)-3-(3-chlorophenyl)propanoicacid;Boc-L-phe(3-Cl)-OH;BOC-L-3-CHLOROPHE;Boc-D-3-Chlorophenylalanine;BOC-L-3-CHLORO-PHE-OH;(S)-N-Boc-3-Chlorophenylalanine;SBB064572;(2S)-2-[(tert-butoxycarbonyl)amino]-3-(3-chlorophenyl)propanoicacid;(R)-N-Boc-3-chlorophenylalanine;(2S)-2-[(tert-butoxy)carbonylamino]-3-(3-chlorophenyl)propanoicacid;(S)-2-(tert-butoxycarbonylamino)-3-(3-chlorophenyl)propanoicacid;(2S)-2-(tert-butoxycarbonylamino)-3-(3-chlorophenyl)propanoicacid;3-Chloro-L-phenylalanine,N-BOCprotected;PubChem18604;Boc-3-Chloro-L-Phe-OH;AC1MC50G;BOC-M-CHLORO-L-PHE-OH;SCHEMBL1519627;CTK7G8923;MolPort-001-758-157;ACN-S004642
M.F/FormulaC14H18ClNO4
M.W/Mr.299.75
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

ICl 154,129 is a new compound that shows selectivity as an antagonist of [Leu5]enkephalin and [D-AIa2, D-Leu5]en ...

 Nafarelin acetate is a gonadotropin-releasing hormone (GnRH) agonist which is as effective as danazol in the tre ...

 NF-кB activator 1, named Act1, is a 60-kDa (574-aa) polypeptide. Based on its interaction with IKKγ, Act1can be ...

What is Trofinetide? Trofinetide is a neuropeptide synthesized from the breakdown product of insulin-like grow ...

The voltage-gated Kv1.3 channel in effector memory T cells serves as a new therapeutic target for multiple scler ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2025 Creative Peptides. All rights reserved.